Chemical Compound
(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide; 5-Heptenamide, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-N-ethyl-, (5Z)- (9CI); AGN 192024; Bimatoprost; Latisse; Lumigan; Prostamide; 5-Heptenamide, 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl]-N-ethyl-, [1R-[1alpha(Z),2beta(1E,3S*),3alpha,5alpha]]-; 17-Phenyltrinor-PGF2alpha ethylamide
CAS Registry Number
155206-00-1
Primary record
(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide; 5-Heptenamide, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-N-ethyl-, (5Z)- (9CI); AGN 192024; Bimatoprost; Latisse; Lumigan; Prostamide; 5-Heptenamide, 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl]-N-ethyl-, [1R-[1alpha(Z),2beta(1E,3S*),3alpha,5alpha]]-; 17-Phenyltrinor-PGF2alpha ethylamide
- 库存
- 7,218 克
- 纯度
- 99.8 %
- CAS
- 155206-00-1
化合物标识与属性
- CAS
- 155206-00-1
- PubChem CID
- 5311027
- SMILES
- CCNC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1/C=C/[C@H](CCC2=CC=CC=C2)O)O)O
- Canonical SMILES
- CCNC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O
名称与同义词
- Bimatoprost
- Lumigan
- Latisse
- Prostamide
- bimatoprostum
- 155206-00-1
- Lumigan (TN)
- DURYSTA
- Bimatoprost/Lumigan
- AGN 192024
- Bimatoprost in bulk
- Lumiga n
- Latisse (TN)
- AC1NSJUW
- ZOLYMBUS
- AGN-192024
- UNII-QXS94885MZ
- RefChem:54542
- BIMATOPROST [MI]
- BIMATOPROST [INN]
- BIMATOPROST [JAN]
- QXS94885MZ
- (5Z)-BIMATOPROST
- BIMATOPROST [USAN]
- D0Q2XF
- BIMATOPROST [VANDF]
- BIMATOPROST [MART.]
- SCHEMBL24425
- BIMATOPROST [WHO-DD]
- C25H37NO4
- CHEBI:51230
- MLS006010039
- US9271961, Bimatoprost
- DTXSID30895042
- AQOKCDNYWBIDND-FTOWTWDKSA-N
- Bimataprost [USAN:INN:BAN]
- Bimatoprost (JAN/USAN/INN)
- BIMATOPROST [EMA EPAR]
- Bimatoprost [USAN:INN:BAN]
- MFCD03411999
- GTPL1958
- orb1305342
- orb3025852
- Bimatoprost (topical, alopecia)
- Bimatoprost [USAN:INN:BAN:JAN]
- CHEMBL1200963
- GANFORT COMPONENT BIMATOPROST
- BIMATOPROST [ORANGE BOOK]
- S01EE03
- AGN192024
- BDBM220120
- DTXCID401324598
- GLXC-05106
- EX-A1769
- HY-B0191
- ZINC4474405
- 192024, AGN
- ABP000616
- C25-H37-N-O4
- EBC-27016
- MSK159263
- AKOS015995566
- ACN-037134
- AM84507
- AN-5283
- CID5311027
- CS-2085
- CS-O-11612
- DB00905
- FB18599
- FD10460
- LS-181817
- RP17728
- CID:5311027
- NCGC00181745-01
- NCGC00181745-03
- AS-35082
- M052
- SMR000058996
- SID:283537485
- AB0015029
- B6165
- FT-0650396
- NS00007742
- J1.596.089B
- D02724
- SBI-0654129.0001
- (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)cyclopentyl)-N-ethylhept-5-enamide
- (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide
- 206B001
- A809623
- C420823
- EN300-21680860
- SR-01000942224
- (Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide
- 17-Phenyl-tri-norprostaglandin F2alpha-ethyl amide
- I06-1275
- I06-1277
- Q2393348
- SR-01000942224-1
- 5-Heptenamide, 7-(3,5-dihydroxy-2-(3-hydrdoxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (1R-(1alpha(Z),2beta(1E,3S*),3alpha,5alpha))-
- 5-Heptenamide, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-, (5Z)-
- D000069580
- (E)-7-[3,5-dihydroxy-2-[(E)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide
- 17-PHENYL TRINOR PROSTAGLANDIN F2ALPHA ETHYL AMIDE
- B0084-340237
- (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl]-N-ethylhept-5-enamide
- (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide
- 17-Phenyl-tri-norprostaglandin F2alpha-ethyl amide, >=95%, solid
- (5E)-5-[4-(difluoromethoxy)benzylidene]-2-mercapto-1,3-thiazol-4(5H)-one
- (5z)-7-{(1r,2r,3r,5s)-3,5-Dihydroxy-2-[(1e,3s)-3-Hydroxy-5-Phenylpent-1-Enyl]cyclopentyl}-N-Ethylhept-5-Enamide
- (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenyl-pent-1-enyl]cyclopentyl]-N-ethyl-hept-5-enamide
- 5-Heptenamide, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (5Z)-
- 5-Heptenamide, 7-(3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (1R-1(alpha(Z),2beta(1E,3S*)3alpha,5alpha))-
- (5Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl)cyclopentyl)-N-ethylhept-5-enamide
- (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide
- (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide; 5-Heptenamide, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-N-ethyl-, (5Z)- (9CI); AGN 192024; Bimatoprost; Latisse; Lumigan; Prostamide; 5-Heptenamide, 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl]-N-ethyl-, [1R-[1alpha(Z),2beta(1E,3S*),3alpha,5alpha]]-; 17-Phenyltrinor-PGF2alpha ethylamide
- (5Z)-N-Ethyl-7-[(1R)-2beta-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]-3alpha,5alpha-dihydroxycyclopentane-1alpha-yl]-5-heptenamide
- (5Z)-N-Ethyl-7-[(1R,2R,3R,5S)-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]-3,5-dihydroxycyclopentane-1-yl]-5-hepteneamide
- (5Z)-N-Ethyl-7-[2beta-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]-3alpha,5alpha-dihydroxycyclopentane-1alpha-yl]-5-hepteneamide
- (5Z,9-alpha,11-alpha,13E,15S)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinorprosta-5,13-dienoic acid ethylamide
- (E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide
- (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((E,3S)-3-hydroxy-5-phenylpent-1-enyl)cyclopentyl)-N-ethylhept-5-enamide
- (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-N-ethyl-5-heptenamide
- 15M
- 5-Heptenamide, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-,(5Z)-
- 5-Heptenamide, 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl]-N-ethyl-, [1R-[1alpha(Z),2beta(1E,3S*),3alpha,5alpha]]-
- 5-Heptenamide,7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ehtyl-,(5Z)